apoM Activators

Apolipoprotein M Activators encompass a diverse range of chemicals, primarily fatty acids and synthetic agonists, that can enhance the expression of Apolipoprotein M (APOM). These compounds exert their impact on APOM by primarily modulating the activity of Peroxisome proliferator-activated receptors (PPARs), a group of nuclear receptor proteins that function as transcription factors regulating the expression of genes, including APOM. The compounds belonging to this class can be broadly categorized into those that activate PPAR-alpha, PPAR-gamma, or PPAR-delta. The PPAR-alpha activators include natural fatty acids like Oleic Acid, Linoleic Acid, Eicosapentaenoic Acid (EPA), and Docosahexaenoic Acid (DHA), as well as synthetic agonists such as WY-14643, Fenofibrate, Clofibrate, and GW7647. These compounds can enhance APOM expression by binding to PPAR-alpha, leading to a conformational change that allows it to bind to PPAR response elements (PPREs) in the APOM gene promoter, subsequently promoting its transcription. The PPAR-gamma activators, Rosiglitazone and Pioglitazone, work in a similar manner, binding to PPAR-gamma and activating APOM transcription.

Lastly, the PPAR-delta activator GW501516 and the pan-PPAR agonist Bezafibrate can stimulate APOM expression by activating PPAR-delta signaling. The wide spectrum of PPAR activators highlights the integral role of PPAR signaling in regulating APOM expression and function. PPAR-alpha activators, we find natural fatty acids such as Oleic Acid, Linoleic Acid, Eicosapentaenoic Acid (EPA), and Docosahexaenoic Acid (DHA). These molecules are essential components of our dietary intake and have shown to affect gene expression by interacting with PPAR-alpha. Synthetic agonists such as WY-14643, Fenofibrate, Clofibrate, and GW7647 also fall under this group. These chemicals are designed to bind specifically to PPAR-alpha and instigate a conformational change in the receptor. This alteration in shape allows PPAR-alpha to bind to PPAR response elements (PPREs) in the promoter region of the APOM gene, leading to an increase in its transcription and thus enhancing the expression of APOM.